Shannon, Harlan E.
Indiana University School of Medicine,
United States
2025 Rank: 115106
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 1049 out of 157499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 115106 | 124283 |
| Total Cites | 5889 | 6663 |
| H-index | 41 | 44 |
| Hm-index | 18 | 18 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 52 | 52 |
| Number of Single+First Authored Papers | 70 | 70 |
| Total Cites to Single+First Authored Papers | 1455 | 1585 |
| Number of Single+First+Last Authored Papers | 112 | 112 |
| Total Cites to Single+First+Last Authored Papers | 2951 | 3205 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4489 | 4814 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.38 |
| Self-Citation Percentage |
11.62%
|
|
Shannon, Harlan E.
Indiana University School of Medicine,
United States
2024 Rank: 104551
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 954 out of 148458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 104551 | 113357 |
| Total Cites | 5911 | 6740 |
| H-index | 42 | 45 |
| Hm-index | 18 | 18 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 49 | 49 |
| Number of Single+First Authored Papers | 70 | 70 |
| Total Cites to Single+First Authored Papers | 1431 | 1547 |
| Number of Single+First+Last Authored Papers | 112 | 112 |
| Total Cites to Single+First+Last Authored Papers | 2898 | 3139 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4505 | 4870 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.38 |
| Self-Citation Percentage |
12.30%
|
|
Shannon, Harlan E.
Indiana University School of Medicine,
United States
2023 Rank: 97386
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 910 out of 140593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 97386 | 105362 |
| Total Cites | 5707 | 6531 |
| H-index | 42 | 45 |
| Hm-index | 18 | 18 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 49 | 49 |
| Number of Single+First Authored Papers | 70 | 70 |
| Total Cites to Single+First Authored Papers | 1384 | 1513 |
| Number of Single+First+Last Authored Papers | 112 | 112 |
| Total Cites to Single+First+Last Authored Papers | 2826 | 3080 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4340 | 4703 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.39 |
| Self-Citation Percentage |
12.62%
|
|
Shannon, Harlan E.
Eli Lilly and Company,
United States
2022 Rank: 93912
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 891 out of 134745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 93912 | 100372 |
| Total Cites | 5192 | 5969 |
| H-index | 40 | 43 |
| Hm-index | 17 | 18 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 49 | 49 |
| Number of Single+First Authored Papers | 69 | 69 |
| Total Cites to Single+First Authored Papers | 1347 | 1475 |
| Number of Single+First+Last Authored Papers | 110 | 110 |
| Total Cites to Single+First+Last Authored Papers | 2746 | 2998 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3857 | 4179 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.43 |
| Self-Citation Percentage |
13.02%
|
|
Shannon, Harlan E.
Eli Lilly and Company,
United States
2021 Rank: 89851
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 865 out of 131063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 89851 | 95888 |
| Total Cites | 5090 | 5858 |
| H-index | 39 | 42 |
| Hm-index | 17 | 18 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 49 | 49 |
| Number of Single+First Authored Papers | 69 | 69 |
| Total Cites to Single+First Authored Papers | 1329 | 1457 |
| Number of Single+First+Last Authored Papers | 110 | 110 |
| Total Cites to Single+First+Last Authored Papers | 2711 | 2963 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3777 | 4097 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.43 |
| Self-Citation Percentage |
13.11%
|
|
Shannon, Harlan E.
Eli Lilly and Company,
United States
2020 Rank: 81868
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 5549 out of 227881 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 81868 | 89728 |
| Total Cites | 4737 | 5438 |
| H-index | 38 | 40 |
| Hm-index | 17 | 18 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 48 | 48 |
| Number of Single+First Authored Papers | 68 | 68 |
| Total Cites to Single+First Authored Papers | 1292 | 1420 |
| Number of Single+First+Last Authored Papers | 109 | 109 |
| Total Cites to Single+First+Last Authored Papers | 2642 | 2894 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3496 | 3768 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.44 |
| Self-Citation Percentage |
12.89%
|
|